chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 17.0
Sex: F
Vaccine: FLU4
Symptoms: Differential white blood cell count, Discomfort, Dizziness, Drug screen, Electrocardiogram
Clinical narrative: Notes 17-year-old otherwise healthy male presents to ED for evaluation of dizziness for the past 6 days. About 6 days ago patient states that he developed dizziness. Patient states that that he feels as though the room is spinning. Patient has had some associated nausea but no vomiting. Patient was evaluated for this at an outside hospital where he was given a migraine cocktail in some fluids. The seem to help symptoms somewhat, however the following day patient experienced dizziness again. Patient was seen at a different outside hospital where they gave him IV fluids. Additionally they got an EKG, blood work, and tested patient's urine. Labs are within normal limits. Patient was also given a dose of meclizine which helped to resolve symptoms. Patient symptoms returned the following morning and if not improved which prompted his visit to the ED today. Patient family has been trying to get in touch with ENT specialist, however they have not been able to make an appointment for any time soon. Patient denies headaches. However he states that his whole body feels heavy. No numbness or tingling or weakness of his extremities. Patient denies chest pains or palpitations. No medications prior to arrival. No recent fevers or illness. No recent head injuries. No other complaints at present.. Review of Systems
Age: 17.0
Sex: F
Vaccine: FLU4
Symptoms: Electrocardiogram abnormal, Full blood count, Magnetic resonance imaging brain, Metabolic function test, Nausea
Clinical narrative: Notes 17-year-old otherwise healthy male presents to ED for evaluation of dizziness for the past 6 days. About 6 days ago patient states that he developed dizziness. Patient states that that he feels as though the room is spinning. Patient has had some associated nausea but no vomiting. Patient was evaluated for this at an outside hospital where he was given a migraine cocktail in some fluids. The seem to help symptoms somewhat, however the following day patient experienced dizziness again. Patient was seen at a different outside hospital where they gave him IV fluids. Additionally they got an EKG, blood work, and tested patient's urine. Labs are within normal limits. Patient was also given a dose of meclizine which helped to resolve symptoms. Patient symptoms returned the following morning and if not improved which prompted his visit to the ED today. Patient family has been trying to get in touch with ENT specialist, however they have not been able to make an appointment for any time soon. Patient denies headaches. However he states that his whole body feels heavy. No numbness or tingling or weakness of his extremities. Patient denies chest pains or palpitations. No medications prior to arrival. No recent fevers or illness. No recent head injuries. No other complaints at present.. Review of Systems
Age: 17.0
Sex: F
Vaccine: FLU4
Symptoms: Platelet count, Ventricular extrasystoles, Vertigo
Clinical narrative: Notes 17-year-old otherwise healthy male presents to ED for evaluation of dizziness for the past 6 days. About 6 days ago patient states that he developed dizziness. Patient states that that he feels as though the room is spinning. Patient has had some associated nausea but no vomiting. Patient was evaluated for this at an outside hospital where he was given a migraine cocktail in some fluids. The seem to help symptoms somewhat, however the following day patient experienced dizziness again. Patient was seen at a different outside hospital where they gave him IV fluids. Additionally they got an EKG, blood work, and tested patient's urine. Labs are within normal limits. Patient was also given a dose of meclizine which helped to resolve symptoms. Patient symptoms returned the following morning and if not improved which prompted his visit to the ED today. Patient family has been trying to get in touch with ENT specialist, however they have not been able to make an appointment for any time soon. Patient denies headaches. However he states that his whole body feels heavy. No numbness or tingling or weakness of his extremities. Patient denies chest pains or palpitations. No medications prior to arrival. No recent fevers or illness. No recent head injuries. No other complaints at present.. Review of Systems
Age: 64.0
Sex: M
Vaccine: FLUC4
Symptoms: Muscle fatigue, Myalgia
Clinical narrative: PATIENT PRESENTED TODAY, 12/18/19, COMPLAINING ABOUT PROLONG MUSCLE FATIGUE AND SORENESS POST VACCINATION.  PATIENT STATED THAT PAIN AND FATIGUE STARTED WITHIN 48 HOURS OF INJECTION OF FLU SHOT IN LEFT ARM.  SYMPTOMS HAVE IMPROVED FOR PATIENT BUT HAVE NOT RESOLVED COMPLETELY AS OF TODAY.
Age: 72.0
Sex: F
Vaccine: FLUA3
Symptoms: Injection site pain, Injection site paraesthesia, Loss of personal independence in daily activities, Neck pain, Pain
Clinical narrative: Patient complains of pain at injection site, pain shooting up her neck for 2 weeks following vaccine, tingling sensation at injection site, pain that continues at injection site and has limited her adls/iadls
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Back pain
Clinical narrative: Patient stated that on day 3 after the administration of the vaccine he started to experience low back pain without a known cause.  He has been treating the pain with ibuprofen which helps some but the pain does not seem to be improving.
Age: 60.0
Sex: F
Vaccine: FLUC4
Symptoms: Anaphylactic reaction, Chest discomfort, Dyspnoea, Pruritus, Urticaria
Clinical narrative: Patient presented to our emergency department for an anaphylactic reaction to a flu vaccination earlier in the day.  Patient received injection around 5pm and began to experience itching and hives around 8pm.  EMS was activated by patient after noting chest tightness and shortness of breath.  She was instructed to call EMS after calling the research nurse line (I'm assuming one her vaccination information sheet).  It is unknown which facility she received her injection at or injection specific information (manufacturer, lot number, etc.).  Patient had noted previous reactions to flu shots though none this severe prior.
Age: 29.0
Sex: F
Vaccine: HEP
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Pediatric dose given and should have been adult, nurse called helpdesk and patient to receive full adult dose ASAP and get 3rd dose on schedule.
Sex: U
Vaccine: DTAPIPVHIB
Symptoms: Product preparation issue
Clinical narrative: a 6 month old patient received the DTAP-IPV portion only from the Pentacel; Initial information received on 25-Jan-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 6 months old patient who was vaccinated with 0.5 ml only DTAP-IPV portion of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL]( batch number: UI966AAA, expiry date: 07-July-2020) via unknown route in right thigh, on 18-Jan-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13); HEPATITIS B VACCINE (HEPATITIS B VACCINE); and ROTAVIRUS VACaCINE LIVE REASSORT ORAL 5V (ROTATEQ) for Immunisation.  It was an actual medication error due to inappropriate reconstitution technique.  It was unknown whether the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: No adverse event, Product preparation issue
Clinical narrative: mixed Pentacel powder with sterile water instead of diluent and gave patient injection, did not reconstitute with the D-TAP/ IPV and is unsure if diluent used was 0.4 percent saline or sterile water , no problems reported; Initial information received on 25-Jan-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a six months old female patient who suppose to vaccinated with a dose of vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (lot UI953AAA and Exp. Date 30-JUN-2020) via unknown route in the left thigh on 24 Jan 2019.  The patient's medical history not reported and concomitant medications included INFLUENZA VACCINE (INFLUENZA VACCINE; PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) and ROTAVIRUS VACCINE (ROTAVIRUS VACCINE) for Immunisation.  It was an actual medication error case due to inappropriate reconstitution technique.  It was reported that, mixed pentacel powder with sterile water instead of diluent and gave patient injection, did not reconstitute with the D-TAP/ IPV and is unsure if diluent used was 0.4 percent saline or sterile water.  No problems were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Age: 1.67
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Product preparation error, Product preparation issue
Clinical narrative: The Hib portion of the vaccine was reconstituted with sterile; Initial information received on 25-Jan-2019 regarding an unsolicited valid non-serious case received from a health care professional (nurse).  This case involves a 20 months old male patient who received vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL].  The patient's past vaccination(s) included HIB VACCINE in 2017 and HIB VACCINE in 2018.  The patient's past medical history, medical treatment(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for Immunisation; and HEPATITIS A VACCINE (HEPATITIS A) for Immunisation.  On 22-Jan-2019, the patient received a first dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE (lot number of  HIB: C5591AA, expiry date: 15-Nov-2019, dose and dose in series not reported) via unknown route in the left thigh.  It was a case of actual medication error due to inappropriate reconstitution technique because the Hib portion of the vaccine was reconstituted with sterile water rather than IPV and the IPV was not given. The administering nurse did not had IPV component at hand.  It was unknown if any adverse event occurred or not following the vaccination.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: F
Vaccine: IPV
Symptoms: Product storage error
Clinical narrative: exposed to temperatures below 35 degrees F for 17 minutes on 03 Jan 2019 and then an additional 24 minutes on 04 Jan 2019; Initial information received on 25-Jan-2019 regarding an unsolicited valid non-serious case received from a nurse.  In this case a cold chain deviation occurred with the dose of IPV (VERO) [IPOL] (] lot N1G411M via unknown route in unknown administration site) which was exposed to temperatures below 35 degrees F for 17 minutes on 03-Jan-2019 and then an additional 24 minutes on 04-Jan-2019.    The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HEPATITIS A VACCINE (HEPATITIS A) for Immunization; MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR) for Immunization; and INFLUENZA VACCINE (INFLUENZA VACCINE) for Immunization.  It was actual medication error due to incorrect product storage. It was reported that the patient was then administered this IPOL vaccine on 21-Jan-2019  It was not reported that the patient had any adverse event  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Age: 49.0
Sex: U
Vaccine: FLU4
Symptoms: No adverse event, Wrong product administered
Clinical narrative: she grabbed a 5ml vial of Tubersol, thinking it was Fluzone Quadrivalent, inadvertently administering 0.5mL of Tubersol to patient, no advesre event; Initial information received on 22-Oct-2019 regarding an unsolicited valid non-serious case from a nurse.  This case is linked to case 2019SA295030 (same reporter).  This case involves a 49 year old patient (gender not reported) who received 0.5 ml dose of TUBERCULIN TEST [TUBERSOL] instead of a dose of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (lot C5588AA and expiration date 17-Jun-2021) via an intramuscular route in the left deltoid on 22-Oct-2019.  Medical history not reported and no other vaccines were received by patient.  It was an actual medication error case due to Wrong product administered.  No adverse event was reported at the time of reporting.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 48.0
Sex: U
Vaccine: FLU4
Symptoms: No adverse event, Wrong product administered
Clinical narrative: she grabbed a 5ml vial of Tubersol, thinking it was Fluzone Quadrivalent, inadvertently administering 0.5mL of Tubersol to patient, no advesre event; Initial information received on 22-Oct-2019 regarding an unsolicited valid non-serious case from a nurse.  This case is linked to case 2019SA295021 (same reporter).  This case involves a 48 year old patient who received 0.5 ml dose of TUBERCULIN TEST [TUBERSOL] instead of a dose of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (lot C5588AA and expiration date 17-Jun-2021) via an intramuscular route in the left deltoid on 22-Oct-2019.  Medical history not reported and no other vaccines were received by patient.  It was an actual medication error case due to Wrong product administered.  No adverse event was reported at the time of reporting.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: M
Vaccine: IPV
Symptoms: Extra dose administered, No adverse event, Wrong patient received product
Clinical narrative: a 16 year old male received a dose of Ipol and Varicella by mistake that was due for another person, no AE; a patient accidentally received an extra dose of Ipol, no AE; Initial information received on 25-Oct-2019 regarding an unsolicited valid non-serious case received from a Physicians Assistant.  This case involves a 16 years old male patient who accidentally received an extra dose of IPV (VERO) [IPOL] by mistake that was due for another person.   The patient's medical history, medical treatments, vaccinations and family history were not provided.   Concomitant vaccinations included VARICELLA VACCINE.  On 24-Oct-2019, the patient received a sixth dose of suspect IPV (VERO) [lot P1F491M, expiry date: 30-NOV-2020] via intramuscular route in unknown administration site.   It was a case of actual medication error due to extra dose administered and wrong patient received product.  The PA reported that a 16 year old male received a dose of Ipol and Varicella by mistake that was due for another person due to the 16 year old having the same first name and the date of birth was not verified prior to administration. The 16 year old patient did need the Varicella but this would make the 6th IPOL vaccine. Patient was fine after the doses.  Outcome was not applicable.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: F
Vaccine: FLU4, FLUR4
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Nurse Practitioner wrote an order for Fluzone Quadrivalent and the Technician gave Flublok Quadrivalent in error to a 13 years old , No AE; 13 years old received Flublok Quadrivalent, no AE; Initial information received on 29-Oct-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 13 years old female patient who experienced 13 years old received flublok quadrivalent (product administered to patient of inappropriate age, wrong product administered), while she received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] instead of  INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 28-Oct-2019, the patient received a one dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot QFAA1939 via intramuscular route in the right arm instead of INFLUENZA QUADRIVAL A-B VACCINE.  It was a case of actual medication error due to product administered to patient of inappropriate age and wrong vaccine administered.  It was reported as Nurse Practitioner wrote an order for Fluzone Quadrivalent and the Technician gave Flublok Quadrivalent in error to a 13 years old.   It was not reported whether the patient had any adverse effect.  It was not reported if the patient received a corrective treatment.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  No further relevant information was reported.
Age: 1.25
Sex: M
Vaccine: DTAP
Symptoms: Expired product administered, No adverse event
Clinical narrative: patient received expired Daptacel, no advesre event; Initial information received on 06-Nov-2019 regarding an unsolicited valid non-serious case from an other health professional.  This case involves a 15 month old male patient who was vaccinated with a 0.5 ml first dose of expired vaccine DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (lot C5281AA and expiration date 05-Oct-2019) via an intramuscular route in the left thigh on 04-Nov-2019.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) and HIB VACCINE (HIB) received on 04-Nov-2019 for immunization.  It was an actual medication error due to expired vaccine used.  No adverse event was reported at the time of reporting.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 10.0
Sex: M
Vaccine: FLUR4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: flublok quadrivalent as it was administered to a 10 year old patient, no adverse event; Initial information received on 28-Oct-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 10 years old male patient who was vaccinated with a 0.5 ml dose of vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] (lot QFAA1963 and expiration date 30-Jun-2020) via an intramuscular route in the left deltoid on 24-Oct-2019.  Medication history not reported and the patient did not received other vaccines.  It was an actual medication error case due to inappropriate age at vaccine administration.  The patient had no adverse event or symptoms.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: M
Vaccine: FLU3
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 54 year old patient was given Fluzone high dose / no AE; 54 year old patient was given Fluzone high dose / no AE; Initial information received on 02-Dec-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 54 years old male patient who received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot number UJ288AB  and Expiry date unknown) via intramuscular route in the left deltoid On 04-Nov-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccination included TDAP.  It was an actual medication error case due Inappropriate age at vaccine administration and overdose.  It was reported that 54 year old patient was given Fluzone high dose.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: M
Vaccine: IPV
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired dose of Ipol was inadvertently administered to patient/No AE; Initial information received on 03-Dec-2019 regarding an unsolicited valid non-serious case from a nurse.  This case involves a 6 years old male patient who received vaccine IPV (VERO) [IPOL] and reported that expired dose of Ipol was inadvertently administered to patient/no AE (expired product administered).  Medical history, medical treatment, vaccination and family history were not provided.  Concomitant medications included DTAP, MMR and VARICELLA.  On 02-Dec-2019, the patient received a dose four of 0.5 mL suspect IPV (VERO) [lot N1K931M, expiry date: 18-NOV-2019] via intramuscular route in the left deltoid.  It was a case of actual medication error due to expired vaccine used.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 4.0
Sex: U
Vaccine: DTAPIPV
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired Quadracel was administered, no AE; Initial information received on 04-Dec-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a four years old patient who was vaccinated with an expired dose of vaccine DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] (lot number not reported and expiry date: 14-Nov-2019) via unknown route in unknown administration site on 04-Dec-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history and concomitant therapies were not provided.  It was actual medication error case due to expired vaccine used.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.
Age: 9.0
Sex: M
Vaccine: HEPA
Symptoms: Dizziness, Fall, Pallor, Syncope
Clinical narrative: Syncope as patient was leaving the office. Patient fell into mother's arms and no injury sustained in fall.  Immediately responsive and oriented, but pallor and lightheadedness with initial attempts to stand. Patient recovered on exam table over course of an hour. He took water and applesauce without difficulty. Orthostatic vital signs on discharge were stable. Patient discharged to home, and follow up phone call confirmed pt doing well.
Age: 69.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Erythema measuring approx 7.3cm by 9.5 cm and pain at injection site
Age: 66.0
Sex: M
Vaccine: UNK
Symptoms: Rash, Skin disorder
Clinical narrative: Patient had rash begin the same day which led to larger rash that was not treated. Patient was seen at Medical Center more than once and then was transferred for higher level of care due to skin condition from Medical Center.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Had a shingles outbreak 5 days after vaccine administered
Age: 34.0
Sex: M
Vaccine: FLU3
Symptoms: Arthralgia, Diarrhoea
Clinical narrative: Per clinic note of 12 Dec 2019: "presents to the clinic with concern for diarrhea, joint pain for  72 hrs.  Patient with history of Crohns, diagnosed several years ago due to sores in his mouth.  He has seen GI in past with colonoscopy and has been on budesonide in past and llialda. Is currently only on oral dexamethasone for mouth sores.  He reports last colonoscopy last year by civilian provider. He has been well controlled.  He does report he was in another country last week and then had flu immunization on [09 Dec 2019]. "
Age: 50.0
Sex: F
Vaccine: HEPA
Symptoms: Condition aggravated, Facial paralysis, Hypoaesthesia, Swelling face
Clinical narrative: Patient complained about numbness in jaw and swelling of one side of the face.
Age: 1.33
Sex: M
Vaccine: MMR
Symptoms: Abnormal behaviour, Anger, Crying, Dyskinesia, Irritability
Clinical narrative: Patient developed fever and irritability on Saturday November 16th around 3pm. Full dose of 1.875 mL of infant's motrin given approximately 3:15pm. Patient was put to sleep around 7pm and awoke several times due to fever. Second full dose of motrin given around 9:45pm. Rectal temperature taken around 11pm upon waking. Temperature was 103.9. Patient was crying and upset throughout the night. Around 2am patient was jerking quickly and repeatedly while crying, which lasted for about 2 minutes. Jerking occured again around 5am and lasted for 2-3 minutes, about one jerk every 5-10 seconds. 3rd dose of motrin given around 5am.  Rectal temperature taken around 5am; result was 103.4. Patient was extremely upset and irritable and appeared to be in pain. Around 5:30am decided he should be seen at the ER.  Patient's fever lasted for 4 days, subsiding on Tuesday November 19th. Patient was lethargic and unable to stay awake for more than  2 hours at a time throughout the day from Sunday November 17th-Friday November 22nd. Patient was lethargic and unresponsive; he was not able to stay awake for more than 2 hours at a time and slept 5-7 hours a day and 12-13 hours at night. His behavior was dramatically different as he is usually very active and aware. Patient began returning to normal behavior on Friday November 22nd; total adverse event lasted for 6 days.
Age: 1.33
Sex: M
Vaccine: MMR
Symptoms: Lethargy, Pyrexia, Somnolence, Unresponsive to stimuli
Clinical narrative: Patient developed fever and irritability on Saturday November 16th around 3pm. Full dose of 1.875 mL of infant's motrin given approximately 3:15pm. Patient was put to sleep around 7pm and awoke several times due to fever. Second full dose of motrin given around 9:45pm. Rectal temperature taken around 11pm upon waking. Temperature was 103.9. Patient was crying and upset throughout the night. Around 2am patient was jerking quickly and repeatedly while crying, which lasted for about 2 minutes. Jerking occured again around 5am and lasted for 2-3 minutes, about one jerk every 5-10 seconds. 3rd dose of motrin given around 5am.  Rectal temperature taken around 5am; result was 103.4. Patient was extremely upset and irritable and appeared to be in pain. Around 5:30am decided he should be seen at the ER.  Patient's fever lasted for 4 days, subsiding on Tuesday November 19th. Patient was lethargic and unable to stay awake for more than  2 hours at a time throughout the day from Sunday November 17th-Friday November 22nd. Patient was lethargic and unresponsive; he was not able to stay awake for more than 2 hours at a time and slept 5-7 hours a day and 12-13 hours at night. His behavior was dramatically different as he is usually very active and aware. Patient began returning to normal behavior on Friday November 22nd; total adverse event lasted for 6 days.
Age: 81.0
Sex: M
Vaccine: VARZOS
Symptoms: Blood immunoglobulin A increased, Blood immunoglobulin E increased, Nodule, Rash pruritic, Tryptase
Clinical narrative: diffuse itchy skin rash and nodules
Age: 59.0
Sex: F
Vaccine: FLU4
Symptoms: Injected limb mobility decreased, Injection site pain, Loss of personal independence in daily activities, Middle insomnia, Musculoskeletal pain
Clinical narrative: THe flu shot was given high into my shoulder and it has caused ongoing pain and loss of movement in my left arm due to pain at injection site.  I have subsequent neck and shoulder/arm pain going on 6 weeks.  It wakes me in the night and causes loss of movement so that easy tasks like getting dressed are difficult and painful.
Age: 59.0
Sex: F
Vaccine: FLU4
Symptoms: Neck pain, Pain, Pain in extremity
Clinical narrative: THe flu shot was given high into my shoulder and it has caused ongoing pain and loss of movement in my left arm due to pain at injection site.  I have subsequent neck and shoulder/arm pain going on 6 weeks.  It wakes me in the night and causes loss of movement so that easy tasks like getting dressed are difficult and painful.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Muscle tightness, Tremor
Clinical narrative: At 10:30 pm,  just after I went to bed, I started shivering violently, though I did not feel sick or cold.  My hands were tremoring severely and my muscles were tight, though I wouldn?t say they were cramping. I tried deep breathing and relaxation with no improvement. After 40 minutes, I got out of bed, sat in a chair and drank hot tea. After another hour the tremors decreased significantly and I went back to bed and fell asleep.
Age: 1.25
Sex: F
Vaccine: DTAP, HIBV, PNC13
Symptoms: Generalised tonic-clonic seizure, Pyrexia
Clinical narrative: Evening after vaccines, patient had 3 brief tonic clonic seizures.  EMS came and gave versed, patient was transported to local ED (hospital).  No report of fever at home, but was starting to have fever at ED (37.8) so they have acetaminophen.  No additional meds given in ED, thought to be complex febrile seizure.  There is a family history of febrile seizures.
Age: 39.0
Sex: F
Vaccine: FLU4, FLU4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received second dose of influenza vaccine 6 weeks apart. No signs or symptoms of adverse events reported by the employee.
Age: 84.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site inflammation, Injection site pain, Injection site swelling
Clinical narrative: Patient experienced soreness. inflammation, redness at site of injection.  The swelling and redness start at site down to almost the elbow area.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Chest X-ray, Computerised tomogram abdomen, Inflammation, Pain, Vaccination complication
Clinical narrative: Onset of severe pain at right dorsal nerve root mid thoracic level, on same side as injection was given; no unusual redness or degree of soreness at injection site. Treated at ER, sent home on toradol for pain and inflammation. Pain gradually resolved over the course of about 3 more days and has not reoccurred. Follow-up 1 1/2 weeks later w/ PCP; concurs that cause was inflammatory response to vaccine and recommends not to receive dose 2 of series.
Age: 3.0
Sex: M
Vaccine: FLU4
Symptoms: Cellulitis, Injection site erythema, Injection site swelling
Clinical narrative: Evening of the vaccination, patient started to have swelling and redness to the left thigh where the shot was given. Mother gave patient Benadryl but symptoms worsened as days went on and eventually came into ED two days later. Patient was discharged with Keflex for what was found to be cellulitis.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Induration, Nodule, Pain, Rash
Clinical narrative: Redness, Pain, Hard knot the size of a fist, rash, lasting 2-3 weeks.
Age: 60.0
Sex: F
Vaccine: UNK
Symptoms: Injection site erythema, Injection site rash, Rash erythematous
Clinical narrative: red rash on sight of injection and some on neck
Age: 70.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Allergy to vaccine, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Patient returned day after vaccination with notable swelling , redness, and warmth at injection sites. She reported it starting the day of vaccination.
Age: 1.0
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Expired product administered, No adverse event
Clinical narrative: An expired MMRII was administered to the left thigh. The expiration date is 11/20/2019. No adverse reactions occurred. Mother was made aware and will bring child back after four weeks for MMR dose.
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Chest discomfort, Fatigue
Clinical narrative: I'd had knee replacement surgery on my left knee on September 25th and had problems with it not completely healing for a week.  Therapy helped me overcome all but the pain in the knee.  On December 12th, I woke up feeling fatigued, as if I had just come home from the hospital. I slept fitfully all day with much pain in my knee.  It subsided about December 13th, then resurfaced again on Monday, December 17th about 5pm with a constriction of my rib cage as if the shingles had come back.  I had to lay in bed most of the evening  to get the pain to subside. Fatigue is still a problem.
Age: 0.17
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Irritability
Clinical narrative: Left leg hot ,red,swollen and very painful. Baby extremely fussy. Ice pack applied for 20 minutes and 80 mg Tylenol given
Age: 36.0
Sex: M
Vaccine: FLU4, FLU4
Symptoms: Body temperature increased, Borrelia test negative, Computerised tomogram, Computerised tomogram normal, Headache
Clinical narrative: i received the flu shot at 2:00pm. i was completely healthy at this time.  by 4:00pm i had a 102 temp. and rash.  over next couple days developed extreme headaches and muscle aches in neck. went to ER Thursday morning 9/26/19 and they said it was a reaction from flu shot to take tylenol for next few days. that did not help so i went back to ER Saturday morning 9/28/19. they admitted me and performed CT scan and performed an unsuccessful lumbar puncture at bed side due to doctor could not get needle into right spot. hopsital than started antibiotics for next two days, monday 9/30/19 had successful lumbar puncture that showed Aseptic meningitis. Spent 3 three more days in hopsital and release 10/2/19 late in afternoon
Age: 36.0
Sex: M
Vaccine: FLU4, FLU4
Symptoms: Influenza, Influenza virus test negative, Lumbar puncture abnormal, Lumbar puncture normal, Meningitis aseptic
Clinical narrative: i received the flu shot at 2:00pm. i was completely healthy at this time.  by 4:00pm i had a 102 temp. and rash.  over next couple days developed extreme headaches and muscle aches in neck. went to ER Thursday morning 9/26/19 and they said it was a reaction from flu shot to take tylenol for next few days. that did not help so i went back to ER Saturday morning 9/28/19. they admitted me and performed CT scan and performed an unsuccessful lumbar puncture at bed side due to doctor could not get needle into right spot. hopsital than started antibiotics for next two days, monday 9/30/19 had successful lumbar puncture that showed Aseptic meningitis. Spent 3 three more days in hopsital and release 10/2/19 late in afternoon
Age: 36.0
Sex: M
Vaccine: FLU4, FLU4
Symptoms: Myalgia, Pyrexia, Rash, Vaccination complication
Clinical narrative: i received the flu shot at 2:00pm. i was completely healthy at this time.  by 4:00pm i had a 102 temp. and rash.  over next couple days developed extreme headaches and muscle aches in neck. went to ER Thursday morning 9/26/19 and they said it was a reaction from flu shot to take tylenol for next few days. that did not help so i went back to ER Saturday morning 9/28/19. they admitted me and performed CT scan and performed an unsuccessful lumbar puncture at bed side due to doctor could not get needle into right spot. hopsital than started antibiotics for next two days, monday 9/30/19 had successful lumbar puncture that showed Aseptic meningitis. Spent 3 three more days in hopsital and release 10/2/19 late in afternoon
Age: 36.0
Sex: M
Vaccine: FLU4, FLU4
Symptoms: Lumbar puncture, Meningitis aseptic, Pyrexia, Rash
Clinical narrative: i received the flu shot at 2:00pm. i was completely healthy at this time.  by 4:00pm i had a 102 temp. and rash.  over next couple days developed extreme headaches and muscle aches in neck. went to ER Thursday morning 9/26/19 and they said it was a reaction from flu shot to take tylenol for next few days. that did not help so i went back to ER Saturday morning 9/28/19. they admitted me and performed CT scan and performed an unsuccessful lumbar puncture at bed side due to doctor could not get needle into right spot. hopsital than started antibiotics for next two days, monday 9/30/19 had successful lumbar puncture that showed Aseptic meningitis. Spent 3 three more days in hopsital and release 10/2/19 late in afternoon
Age: 36.0
Sex: M
Vaccine: FLU4, FLU4
Symptoms: Body temperature increased, Borrelia test negative, Computerised tomogram, Computerised tomogram normal, Headache
Clinical narrative: PATIENT HAD A FEVER FEW HOURS AFTER RECEIVING THE VACCINE, ALSO REPORTED A RASH. PATIENT WENT TO THE HOSPITAL AND WAS HOSPITALIZED. HOSPITAL TOLD HIM HE HAD ASEPTIC MENINGITIS.
Age: 36.0
Sex: M
Vaccine: FLU4, FLU4
Symptoms: Influenza, Influenza virus test negative, Lumbar puncture abnormal, Lumbar puncture normal, Meningitis aseptic
Clinical narrative: PATIENT HAD A FEVER FEW HOURS AFTER RECEIVING THE VACCINE, ALSO REPORTED A RASH. PATIENT WENT TO THE HOSPITAL AND WAS HOSPITALIZED. HOSPITAL TOLD HIM HE HAD ASEPTIC MENINGITIS.
Age: 36.0
Sex: M
Vaccine: FLU4, FLU4
Symptoms: Myalgia, Pyrexia, Rash, Vaccination complication
Clinical narrative: PATIENT HAD A FEVER FEW HOURS AFTER RECEIVING THE VACCINE, ALSO REPORTED A RASH. PATIENT WENT TO THE HOSPITAL AND WAS HOSPITALIZED. HOSPITAL TOLD HIM HE HAD ASEPTIC MENINGITIS.
Age: 36.0
Sex: M
Vaccine: FLU4, FLU4
Symptoms: Lumbar puncture, Meningitis aseptic, Pyrexia, Rash
Clinical narrative: PATIENT HAD A FEVER FEW HOURS AFTER RECEIVING THE VACCINE, ALSO REPORTED A RASH. PATIENT WENT TO THE HOSPITAL AND WAS HOSPITALIZED. HOSPITAL TOLD HIM HE HAD ASEPTIC MENINGITIS.
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Chest discomfort, Cough, Fatigue, Headache, Heart rate increased
Clinical narrative: "Tightening of my heart and a headache" started the evening of the same day vaccine was administrated. Flu-like symptoms proceeded the next day (8/30/19) through 9/13/19 (2 weeks). Those flu-like symptoms were "snotty/runny/stuffy nose, persistent cough, achy, fatigue, and increased heart rate. "
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Influenza like illness, Nasal congestion, Pain, Rhinorrhoea
Clinical narrative: "Tightening of my heart and a headache" started the evening of the same day vaccine was administrated. Flu-like symptoms proceeded the next day (8/30/19) through 9/13/19 (2 weeks). Those flu-like symptoms were "snotty/runny/stuffy nose, persistent cough, achy, fatigue, and increased heart rate. "
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: Patient called on 12/17/2019 and stated that she recieved shingrix vaccine at the pharmacy on 09/29/19 and her arm has been hursting ever since.
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Rash
Clinical narrative: -Pt reported redness/swelling/soreness 4-5 inches below the injection site. Rash is contained on one area of the arm and not spreading. No blisters or oozing from the affected area -This reporting is within 48 hours of vaccine administration and patient reported feeling better although the rash is still present No additional symptoms  Pt not sure if the soreness is from rash or from the vaccination itself
Age: 57.0
Sex: F
Vaccine: PPV, VARZOS
Symptoms: Injection site pruritus, Injection site urticaria
Clinical narrative: patient came in on Tuesday 12/17/19 reporting hives on upper right arm.  she showed Pharmacist the hives. they were not directly at injection site but in the general area of injection site.  Patient had 2 hives (red raised wheals).  she stated they weren't that itchy but she could notice them.   Pharmacist recommended taking antihistamine, patient reported that she takes daily zyrtec.  Pharmacist stated she could add oral Benadryl if needed.  Pharmacist also recommended topical hydrocortisone, patient reported she had topical clobetasol at home she could use if needed.  Pharmacist recommended that patient notify her MD of reaction so they could notate in her chart as they may not want to repeat the dose after age 65 when she is due again.  patient called back and told me she did notify her doctor's office for them to update her chart.
Age: 46.0
Sex: F
Vaccine: FLU4
Symptoms: Chills, Full blood count, Investigation, Malaise, Pyrexia
Clinical narrative: High fever 104 Chills Malaise
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Mobility decreased
Clinical narrative: Patient called two hours after receiving Shingrix and stated she was having difficulty moving her arm.  She followed up with her PCP who prescribed lidocaine cream to help with pain.  It was too expensive so she used the OTC version of lidocaine.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, FLU4, MMRV
Symptoms: Abnormal behaviour, Aggression, Anger, Irritability, Pyrexia
Clinical narrative: Day #1 after vaccine - fever Day # 3 after vaccine - clingy/fussy Day #4- 8 after vaccine - irritable, angry, biting - very abnormal behavior for child by both family and longstanding daycare provider.  Will have improved behavior at times.
Age: 46.0
Sex: F
Vaccine: FLUR4
Symptoms: Injection site bruising, Injection site pruritus, Injection site rash
Clinical narrative: patient received vaccine on the afternoon of 12/15/19. Starting the evening of 12/16, she noticed redness, raised bumps and the arm where she got shot. It was also itchy
Age: 1.08
Sex: F
Vaccine: IPV, MMR
Symptoms: Dyspraxia, Epilepsy, Febrile convulsion, Gait disturbance, Muscle twitching
Clinical narrative: Febrile seizure, high fevers up to 102.8  starting evening of 12/17, 8 days after first MMR vaccination (no varicella) with a 10s febrile seizure noted - eyes open, absence/staring with rhythmic full body myoclonus, unresponsive, cried after event.  Abrupt, intense whole body Myoclonus continued throughout 12/18, high fevers, involuntary facial twitches while Awake, unsteady gait, walking into walls/furniture as if in a daze,   All symptoms present without presence of any other illness or infection; no uri symptoms (sneeze cough or runny nose, current or recent, no pain signs related to ears, mouth, or throat. No gi symptoms (eating and drinking, no vomiting no diarrhea) no gu symptoms (abnormal urine) integumentary (no rashes)   6.5 year old male sibling had same symptoms after MMRV vaccination, later diagnosed with epilepsy and subsequent childhood apraxia of speech.
Age: 1.08
Sex: F
Vaccine: IPV, MMR
Symptoms: Myoclonus, Pyrexia, Staring
Clinical narrative: Febrile seizure, high fevers up to 102.8  starting evening of 12/17, 8 days after first MMR vaccination (no varicella) with a 10s febrile seizure noted - eyes open, absence/staring with rhythmic full body myoclonus, unresponsive, cried after event.  Abrupt, intense whole body Myoclonus continued throughout 12/18, high fevers, involuntary facial twitches while Awake, unsteady gait, walking into walls/furniture as if in a daze,   All symptoms present without presence of any other illness or infection; no uri symptoms (sneeze cough or runny nose, current or recent, no pain signs related to ears, mouth, or throat. No gi symptoms (eating and drinking, no vomiting no diarrhea) no gu symptoms (abnormal urine) integumentary (no rashes)   6.5 year old male sibling had same symptoms after MMRV vaccination, later diagnosed with epilepsy and subsequent childhood apraxia of speech.